Fritz, I., Wagner, P., Bottai, M., Eriksson, H., Ingvar, C., Krakowski, I., . . . Lund University, P. a. a. o. s. r. e. (2020). Desloratadine and loratadine use associated with improved melanoma survival. Allergy Improved cancer survival with use of common antihistamines. Epidemiological studies on the use of H1-antihistamines and survival in cancer., 75(8), 2096. https://doi.org/10.1111/all.14273
Chicago Style (17th ed.) CitationFritz, Ildikó, et al. "Desloratadine and Loratadine Use Associated with Improved Melanoma Survival." Allergy Improved Cancer Survival with Use of Common Antihistamines. Epidemiological Studies on the Use of H1-antihistamines and Survival in Cancer. 75, no. 8 (2020): 2096. https://doi.org/10.1111/all.14273.
MLA (9th ed.) CitationFritz, Ildikó, et al. "Desloratadine and Loratadine Use Associated with Improved Melanoma Survival." Allergy Improved Cancer Survival with Use of Common Antihistamines. Epidemiological Studies on the Use of H1-antihistamines and Survival in Cancer., vol. 75, no. 8, 2020, p. 2096, https://doi.org/10.1111/all.14273.